Children and antibiotics: analysis of reduced use, 1996-2001

G Edward Miller1, Julie Hudson

  • 1Division of Modeling and Simulation, Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, Rockville, Maryland 20850, USA. emiller@ahrq.gov

Medical Care
|April 21, 2006
PubMed

Insights

Antibiotic use in U.S. children decreased significantly from 1996-2001, particularly for respiratory infections. This decline reflects a positive response to national campaigns promoting appropriate antibiotic prescribing practices.

Area of Science:

  • Pediatric Health
  • Public Health Interventions
  • Antibiotic Stewardship

Background:

  • National campaigns aimed to improve appropriate antibiotic use among U.S. children.
  • Understanding trends in pediatric antibiotic consumption is crucial for antimicrobial stewardship.

Purpose of the Study:

  • To investigate trends in antibiotic use among U.S. children between 1996 and 2001.
  • To analyze the impact of national campaigns on antibiotic prescribing patterns.

Main Methods:

  • Utilized nationally representative data from the Medical Expenditure Panel Survey (1996-2001).
  • Examined trends in overall antibiotic use and use for respiratory tract infections.
  • Analyzed trends across different racial/ethnic and income subgroups.

Main Results:

  • Overall antibiotic use in children decreased by 8.5 percentage points from 1996-2001.
  • Antibiotic use for respiratory infections declined by 5.1 percentage points.
  • Reductions in antibiotic use were observed across all examined pediatric subgroups.

Conclusions:

  • Significant declines in pediatric antibiotic use were observed during the study period.
  • These reductions suggest a widespread positive response to public health campaigns promoting judicious antibiotic prescribing.
  • Findings indicate successful implementation of antibiotic stewardship initiatives in a large pediatric population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...